Showing 1 - 3 results of 3 for search 'P. E. Westerweel', query time: 0.02s
Refine Results
-
1
S157: BCR::ABL1 DIGITAL PCR IDENTIFIES CHRONIC PHASE CML PATIENTS SUITABLE FOR AN EARLY TKI DISCONTINUATION ATTEMPT: A PATIENT-LEVEL META-ANALYSIS by C. Kockerols, S. Dulucq, S. Bernardi, M. Farina, I. Civettini, G. Colafigli, S. Mori, P. Valk, F.-X. Mahon, C. Gambacorti-Passerini, F.-E. Nicolini, M. Breccia, D. Russo, P. E. Westerweel
Published 2022-06-01
Article -
2
Early-stage measurable residual disease dynamics and IGHV repertoire reconstitution during venetoclax and obinutuzumab treatment in chronic lymphocytic leukemia by P. J. Hengeveld, J. Schilperoord-Vermeulen, M. Y. van der Klift, J. M. N. Dubois, P. M. Kolijn, F. G. Kavelaars, M. Rijken, J. A. Dobber, K. Nasserinejad, S. Kersting, P. E. Westerweel, A. P. Kater, A. W. Langerak, M-D. Levin
Published 2023-07-01
Article -
3
P709: CLINICAL OUTCOME OF ASCIMINIB TREATMENT IN A REAL-WORLD MULTI-RESISTANT CML PATIENT POPULATION. by C. C. Kockerols, J. J. Janssen, N. M. Blijlevens, S. K. Klein, L. G. van Hussen-Daenen, G. N. van Gorkom, W. M. Smit, P. van Balen, B. J. Biemond, M. J. Cruijsen, M. F. Corsten, P. A. te Boekhorst, H. R. Koene, G. L. van Sluis, J. J. Cornelissen, P. E. Westerweel
Published 2022-06-01
Article